Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study.

Fausto Roila,Enzo Ballatori,Benedetta Ruggeri,Sonia Fatigoni,Aurora Mirabile,Barbara Frau,Luigi Cavanna,Sergio Fava,I. Colantonio,Lucia Angelelli,Libero Ciuffreda,Stefania Eufemia Lutrino,F. Zerilli

Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study.

2014

Fausto Roila
Enzo Ballatori
Benedetta Ruggeri
Sonia Fatigoni
Aurora Mirabile
Barbara Frau
Luigi Cavanna
Sergio Fava
I. Colantonio
Lucia Angelelli
Libero Ciuffreda
Stefania Eufemia Lutrino
F. Zerilli

9503 Background: A combination of aprepitant, a 5-HT3 receptor antagonist, and dexamethasone is recommended for the prophylaxis of cisplatin-induced nausea and vomiting in acute phase, and aprepita...

Keywords:

Physical therapy
Anesthesia
Dexamethasone
Aprepitant
Cisplatin
Metoclopramide
Medicine
Vomiting
Nausea
Pharmacology
double blind study
Pathology
Receptor antagonist

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations